CD36 was recently described to be involved in NASH, as its expression is elevated in ob/ob mice, db/db mice and mice fed a high-fat diet, and highly correlates with hepatic triglyceride content30. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatohepatitis.